SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Association of Life's Simple 7 lifestyle metric with cardiometabolic disease-free life expectancy in older British men.

Wang, Q; Schmidt, AF; Lennon, LT; Papacosta, O; Whincup, PH; Wannamethee, G (2024) Association of Life's Simple 7 lifestyle metric with cardiometabolic disease-free life expectancy in older British men. Commun Med (Lond), 4 (1). p. 104. ISSN 2730-664X https://doi.org/10.1038/s43856-024-00534-7
SGUL Authors: Whincup, Peter Hynes

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (707kB) | Preview
[img]
Preview
PDF (Peer Review File) Supplemental Material
Available under License Creative Commons Attribution.

Download (3MB) | Preview
[img]
Preview
PDF (Supplementary Information) Supplemental Material
Download (271kB) | Preview
[img]
Preview
PDF (Reporting Summary) Supplemental Material
Download (72kB) | Preview

Abstract

BACKGROUND: Cardiometabolic diseases (CMD), including myocardial infarction, stroke, and type 2 diabetes, are leading causes of disability and mortality globally, particularly for people at an older age. The impact of adhering to the Life's Simple 7 (LS7) on the number of years an individual will live without CMD in older adults remains less studied. METHODS: This study included a cohort of 2662 British men aged 60-79 years free of CMD at baseline from the British Regional Heart Study (BRHS). Each LS7 factor (BMI, blood pressure, blood glucose, total cholesterol, smoking, physical activity, and diet) was categorized as poor, intermediate, or ideal, and a composite LS7 adherence was determined by summing the number of LS7 ideal levels achieved. Flexible parametric Royston-Parmar proportional-hazards model was applied to estimate CMD-free life expectancy. RESULTS: Here we show that compared to men with the lowest LS7 adherence [with 18.42 years (95% CI: 16.93, 19.90) of CMD-free life at age 60], men having an ideal LS7 adherence are estimated to gain an additional 4.37 years (95% CI: 2.95, 5.79) of CMD-free life. The CMD-free life gain benefits are consistent across social class groups of manual and non-manual workers. Among LS7 factors, achieving an ideal physical activity provides the largest CMD-free survival benefit: 4.84 years (95% CI: 3.37, 6.32) of additional CMD-free life compared with the physically inactive group. CONCLUSIONS: Our study quantifies and highlights the benefits of adhering to the LS7 ideal levels for living a longer life without CMD in older adults.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2024
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Academic Structure > REF 2021 user group
Journal or Publication Title: Commun Med (Lond)
ISSN: 2730-664X
Language: eng
Dates:
DateEvent
4 June 2024Published
29 May 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
RG/19/4/34452British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/22/10989British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
AA/18/6/34223British Heart FoundationUNSPECIFIED
MR/V033867/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDNational Institute for Health and Care Research University College London Hospitals Biomedical Research CentreUNSPECIFIED
PubMed ID: 38834824
Web of Science ID: WOS:001238655300001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116681
Publisher's version: https://doi.org/10.1038/s43856-024-00534-7

Actions (login required)

Edit Item Edit Item